Gary S. Hogge - Net Worth and Insider Trading
Gary S. Hogge Net Worth
The estimated net worth of Gary S. Hogge is at least $0 dollars as of 2023-03-20. Gary S. Hogge is the SVP,Clinical & Medical Affairs of Lineage Cell Therapeutics Inc and owns about 0 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $0. Details can be seen in Gary S. Hogge's Latest Holdings Summary section.
Transaction Summary of Gary S. Hogge
Gary S. Hogge Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary S. Hogge owns 1 companies in total, including Lineage Cell Therapeutics Inc (LCTX) .
Click here to see the complete history of Gary S. Hogge’s form 4 insider trades.
Insider Ownership Summary of Gary S. Hogge
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2019-03-19 | SVP,Clinical & Medical Affairs |
Gary S. Hogge Latest Holdings Summary
Gary S. Hogge currently owns a total of 1 stock. Gary S. Hogge owns 0 shares of Lineage Cell Therapeutics Inc (LCTX) as of December 29, 2021, with a value of $0.
Latest Holdings of Gary S. Hogge
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics Inc | 2021-12-29 | 0 | 1.41 | 0 |
Holding Weightings of Gary S. Hogge
Gary S. Hogge Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary S. Hogge has made a total of 1 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 539,283 shares on December 29, 2021, which brought Gary S. Hogge around $1 Million.
Insider Trading History of Gary S. Hogge
- 1
Gary S. Hogge Trading Performance
Gary S. Hogge Ownership Network
Ownership Network List of Gary S. Hogge
Ownership Network Relation of Gary S. Hogge
Gary S. Hogge Owned Company Details
What does Lineage Cell Therapeutics Inc do?
Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline is based on two platform technologies including cell replacement and cell/drug delivery. Lineage Cell's product candidate is OpRegen, a retinal pigment epithelium transplant therapy for the treatment of dry age-related macular degeneration, OPC1, an oligodendrocyte progenitor cell therapy for acute spinal cord injuries, and VAC2, allogeneic cancer immunotherapy of antigen-presenting dendritic cells for non-small cell lung cancer, ANP1, an allogeneic auditory neuron progenitor cell transplant for hearing loss, and PNC1, an allogeneic photoreceptor cell transplant for vision loss.
Who are the key executives at Lineage Cell Therapeutics Inc?
Gary S. Hogge is the SVP,Clinical & Medical Affairs of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , General Counsel/Secretary Samuel George A. Iii , and Chief Financial Officer Kevin Leon Cook .
Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary
Over the past 18 months, Gary S. Hogge made 1 insider transaction in Lineage Cell Therapeutics Inc (LCTX) with a net sale of 539,283. Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 930,106 shares made by Broadwood Partners Lp , a net purchase of 35,000 shares made by Dipti Amin , and a net purchase of 7,000 shares made by Michael H. Mulroy .
In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 539,283 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 977,356 shares were bought by its insiders, resulting in a net purchase of 438,073 shares.
Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMEX:LCTX Insider Transactions
Gary S. Hogge Mailing Address
Above is the net worth, insider trading, and ownership report for Gary S. Hogge. You might contact Gary S. Hogge via mailing address: 1010 Atlantic Avenue, Suite 102, Alameda Ca 94501.
